title: The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide.
abstract: We identified a novel missense mutation in the apolipoprotein A-I gene, T2069C Leu(174) --> Ser, in a patient affected by familial systemic nonneuropathic amyloidosis. The amyloid deposits mostly affected the heart of the proband, who underwent transplantation for end-stage congestive heart failure. Amyloid fibrils of myocardial and periumbilical fat samples immunoreacted exclusively with anti-ApoA-I antibodies. Amyloid fibrils extracted from the heart were constituted, according to amino acid sequencing and mass spectrometry analysis, by an amino-terminal polypeptide ending at Val(93) of apolipoprotein A-I (apoA-I); no other significant fragments were detected. The mutation segregates with the disease; it was demonstrated in the proband and in an affected uncle and excluded in three healthy siblings. The plasma levels of high-density lipoprotein and apoA-I were significantly lower in the patient than in unaffected individuals. This represents the first case of familial apoA-I amyloidosis in which the mutation is outside the polypeptide fragment deposited as fibrils. Visualization of the mutation in the three-dimensional structure of lipid-free apoA-I, composed of four identical polypeptide chains, indicates that position 174 of one chain is located near position 93 of an adjacent chain and suggests that the amino acid replacement in position 174 is permissive for a proteolytic split at the C-terminal of Val(93).
authors.affiliation: Biotechnology Research Laboratories, Institute of Human Pathology, Division of Cardiology, IRCCS Policlinico San Matteo, Pavia, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Obici
authors.forename: V
authors.initials: V
authors.lastname: Bellotti
authors.forename: P
authors.initials: P
authors.lastname: Mangione
authors.forename: M
authors.initials: M
authors.lastname: Stoppini
authors.forename: E
authors.initials: E
authors.lastname: Arbustini
authors.forename: L
authors.initials: L
authors.lastname: Verga
authors.forename: I
authors.initials: I
authors.lastname: Zorzoli
authors.forename: E
authors.initials: E
authors.lastname: Anesi
authors.forename: G
authors.initials: G
authors.lastname: Zanotti
authors.forename: C
authors.initials: C
authors.lastname: Campana
authors.forename: M
authors.initials: M
authors.lastname: Viganò
authors.forename: G
authors.initials: G
authors.lastname: Merlini
mesh_terms: D019943:Amino Acid Substitution; D000682:Amyloid / Q000737:chemistry* / Q000648:ultrastructure; D000686:Amyloidosis / Q000150:complications / Q000235:genetics*; D016632:Apolipoprotein A-I / Q000737:chemistry / Q000235:genetics*; D002850:Chromatography, Gel; D006331:Heart Diseases / Q000209:etiology*; D006801:Humans; D008297:Male; D013058:Mass Spectrometry; D008875:Middle Aged; D008958:Models, Molecular; D008970:Molecular Weight; D009206:Myocardium / Q000737:chemistry / Q000648:ultrastructure; D010446:Peptide Fragments / Q000737:chemistry* / Q000648:ultrastructure; D017354:Point Mutation / Q000235:genetics; D016133:Polymerase Chain Reaction; D017422:Sequence Analysis, DNA
chemical_list: D000682:Amyloid; D016632:Apolipoprotein A-I; D010446:Peptide Fragments